Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 13, 1997

View Archived Issues

AGE inhibitors reported by Kissei

Novel antiarrhythmic agents described by Merck & Co.

Anticancer agents from Takeda

Pfizer claims 5-LO inhibitors

Sugen reports modulators of tyrosine signal transduction

Neutrophil-stimulating peptides derived from TNF described by Peptech

PPL reports progress in transgenic cow program

Alza obtains rights to opioid analgesic and licenses the product to Knoll

U.S. patent covers DLK gene

FDA approves product for hemophilia

Encouraging phase IIb results for antiparkinsonian patch

ABS moves to Boston

IND filed for novel HIV treatment from Steroidogenesis Inhibitors

Orphan Medical expands clinical trials of Busulfanex

Harvard Scientific's impotence drug advances in European trials

Patent coverage for lung cancer detection technology

Supplemental NDA filed for Photofrin

Penederm receives U.K. marketing approval for topical acne treatment

Basal lamina-based drugs offer promise for tumor metastasis

Lilly/Taisho sign technology transfer agreement

Idec acquires rights to anticancer agent

DiagnoCure prepares for clinical trials of bladder cancer diagnostic

Paroxetine inhibits NOS

Valproate efficacy in major depressive disorder

ICOS' Hu23F2G enters phase II

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...